RAFFLES ASSOCIATES LP LCTX Holdings History
RAFFLES ASSOCIATES LP's Lineage Cell Therapeutics Inc Holding Summary
As of 2025-03-31, RAFFLES ASSOCIATES LP held 5.64 Mil shares of Lineage Cell Therapeutics Inc(LCTX), totaling $2.55 Mil. This investment constitutes 3.1% of their stock portfolio, and RAFFLES ASSOCIATES LP now holds 2.47% of the outstanding Lineage Cell Therapeutics Inc(LCTX) stock.
The initial trade took place in 2018Q2. And since then RAFFLES ASSOCIATES LP has made 14 purchases of LCTX, at an average price of $1.24, for a total of 6.24 Mil shares. In addition, there have been 3 sales at an average price of $1.35 for 598,590.00 shares. Based on historical transaction data and LCTX's current price of $0.99, RAFFLES ASSOCIATES LP's estimated gain on his LCTX holdings is $-1.31 Mil, reflecting a -16.99% gain to date.
RAFFLES ASSOCIATES LP LCTX ($0.99) Holding Chart
RAFFLES ASSOCIATES LP LCTX ($0.99) Quarterly Buys and Sells
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
|---|---|---|---|---|
| Shares Bought | 0 | Average Price $-/Share | ||
| Shares Sold | 0 | Average Price $-/Share | ||
| Current Price $0.00 | Total Estimated Gain 0 % | |||
Top Ranked Articles
- 1
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
